Russian clinical course protocols
- Reported quantity
- 5–10 mg per administration
- Frequency
- Once daily
- Study duration
- 10-day courses, repeated periodically
The 10-day course structure again defines this family of peptides.
Protocols · Longevity
Cartalax: literature-reported ranges
Cartalax is the cartilage-directed member of the Khavinson short-peptide family, studied for connective-tissue and joint parameters. Like Pinealon and Epithalon, its evidence base is small and regionally concentrated.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Compound at a glance
- Class
- Synthetic tripeptide (Ala-Glu-Asp) bioregulator
- Reported half-life
- Minutes in plasma
- Routes used in the literature
- Intramuscular in the published Russian protocols
- Also written as
- —
What the published studies reported
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
Cell-culture chondrocyte studies
- Reported quantity
- Nanomolar to low micromolar in media
- Frequency
- Single exposure per media change
- Study duration
- 24–72 hours
Gene-expression changes in cartilage cells are the reported endpoint.
Dosage chart
These figures match the published chart for this compound on peptidedosages.com, including the reconstitution volume, resulting concentration, insulin-syringe units and the staged schedule. Educational reference only — not instructions, and not medical advice.
Cartalax · 20 mg Vial
Cartalax is dosed at 2 mg–5 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
- Reconstitute
- Add 3.0 mL bacteriostatic water → ~ 6.67 mg/mL concentration.
- Example daily range
- 2,000–5,000 mcg once daily (gradual titration).
- Easy measuring
- At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
- Storage
- Lyophilized: store at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F) for long‑term; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
| Week/Phase | Daily Dose (mcg / mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 2,000 mcg (2.0 mg) | 30 units (0.30 mL) |
| Weeks 3–4 | 3,000 mcg (3.0 mg) | 45 units (0.45 mL) |
| Weeks 5–8 | 4,000 mcg (4.0 mg) | 60 units (0.60 mL) |
| Weeks 9–12 | 5,000 mcg (5.0 mg) | 75 units (0.75 mL) |
Reconstitution maths
A 10 mg vial in 2 mL of bacteriostatic water gives 5 mg/mL.
Open the reconstitution calculatorHow to read these figures
- As with the whole bioregulator family, independent replication is the missing piece.
- Tripeptide stability and tissue targeting claims are proposed rather than demonstrated.
- Joint-outcome claims exceed what the published endpoints measured.
Sources and citations
No peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.
Search the databases yourself
Read the Cartalax research briefOther longevity compounds
EpithalonSynthetic tetrapeptide (Ala-Glu-Asp-Gly)FOXO4-DRIFOXO4-p53 interaction-disrupting retro-inverso peptideGlutathioneEndogenous tripeptide antioxidant (Glu-Cys-Gly)Humanin24-amino-acid mitochondrial-derived peptide
All research protocolsPeptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.